All the Active Ingredient Drugs
ORSERDU
Stemline Israel Ltd.
ORSERDU
Estrogen Receptor Antagonist. Elacestrant 86 mg, 345 mg. FC tab 86/345 mg
345 mg once dly until dis. progress. or unaccept. tox.
tmt. of postmenopausal women or adlt. men with estrogen recept. (ER)-pos., human epidermal growth fact. recept. 2 (HER)-neg., ESR1-mutated adv. or metast. breast cancer with dis. progr. follow. at least 1 line of endocr. ther.
C/I: Hypersens.